LINK-IT: Leveraging vIdeos and commuNity Health worKers to Improve Diabetes OuTcomes
Part of paid clinical trials in New York, New York.
- Sponsor
- NYU Langone Health
- Study ID
- NCT06319716
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Video-Based Diabetes Self-Management Education and Support (DSMES) — BEHAVIORALThe DSMES videos provide important diabetes education to participants and empower them to become an activated patient on the individual level.
- Community Health Worker (CHW) Support — BEHAVIORALCHWs will assess participants' social determinants of health (SDOH) barriers to Type 2 diabetes care and link them to available resources in the community.
Study Details
The overall goal of this study is to examine the efficacy of the video-based Diabetes Self-Management Education and Support (DSMES) (hereafter VIDEO), or the video-based DSMES+community health worker (CHW) intervention (hereafter VIDEO+CHW), compared with a wait-list control group (hereafter CONTROL) to improve glycemic control among Chinese immigrants with uncontrolled Type 2 diabetes in NYC.
Key Dates
- Start date
- Dec 29, 2024
- Status verified
- May 2026
- Primary completion
- Dec 31, 2027
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 540 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: VIDEOParticipants assigned to the VIDEO arm will receive one brief Diabetes Self-Management Education and Support (DSMES) video per week for 24 weeks. The videos will be delivered via text message.
- Experimental: VIDEO+CHWParticipants assigned to the VIDEO+CHW arm will receive one brief DSMES video per week, in addition to bi-weekly support calls from a community health worker (CHW), for 24 weeks. The DSMES videos will be delivered via text message.
- No Intervention: CONTROLParticipants assigned to the CONTROL group will continue to receive usual care.
Primary Outcome Measure
Hemoglobin A1c (HbA1c) Levels [ Time Frame: Baseline ]
Central Contacts
- Lu Hu, PhD646-501-3438
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NYU Langone Health | New York | New York | 10016 | - |
Find similar trials in New York, NY
By condition
By specialty
By research site
Related Studies
- Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes PatientsPHASE1/PHASE2 · Not Yet Recruiting · ARKAY Therapeutics · Albany, New York
- Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes MellitusNot Yet Recruiting · Bionime Corporation · Guntersville, Alabama
- Novel Digital Patient-Reported Outcomes Tool for Diabetes ManagementRecruiting · NYU Langone Health · New York, New York
- Implementing an Effective Diabetes Intervention Among Low-Income ImmigrantsRecruiting · NYU Langone Health · New York, New York